Immunoscore® is now available in Rectal Cancer for expert clinical centers through an Innovation Access Program

NEXT STORY
InveniAI Appoints Industry Leader Dr. Salvatore Alesci as Chief Scientific Officer to Advance AI-Powered Portfolio of Assets Targeting Dysregulation of the Gut-Brain Axis
PREV STORY
LexaGene Expands its Sales Team
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche launches the AVENIO Edge System to simplify and automate next-generation sequencing sample preparation, reduce human error and advance precision medicine

author_avatar
NASDAQ Market News

FDA accepts application for Roche’s faricimab for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)

author_avatar
NASDAQ Market News

Beta-Carotene Market To Reach USD 654.0 Million By 2027 Growing at a CAGR of 3.3% | Reports and Data

author_avatar
NASDAQ Market News